SPI Pharma
Trending Articles
Related Content
Ingredients
Engineering compendial mannitol for orally dispersible applications
Regulators are increasingly insisting that formulators consider patient centricity during formulation development; as such, the organoleptic properties of the final dosage form must be considered at the start
of any project, writes SPI Pharma's Graeme Macleod and Wayne Camarco